Accumulation of promoter methylation suggests epigenetic progression in squamous cell carcinoma of the esophagus

Mingzhou Guo, Jingli Ren, Michael House, Yu Qi, Malcolm V. Brock, James G. Herman

Research output: Contribution to journalArticle

84 Citations (Scopus)

Abstract

Purpose: Squamous esophageal cancer is common in non-Western countries and has a well-defined progression of preinvasive dysplasia leading to invasive squamous cell carcinoma. We examined the changes in promoter region methylation occurring during neoplastic progression. Experimental Design: The frequency of epigenetic changes in the promoter region of 14 genes epigenetically silenced in other cancers was determined and examined the most frequent changes in dysplastic lesions using methylation-specific PCR. Invasive squamous carcinomas, low to high grade dysplasia, and normal esophagus were then examined for methylation changes in the promoter region of each of the eight most commonly methylated genes. Results: Methylation was most frequent for CDKN2A/p16INK4a (52%) but was also common for O6-methylguanine-DNA methyltransferase, E-cadherin (CDH1), and retinoic acid receptor β2. Methylation at individual genes increased in frequency from normal to invasive cancer. Methylation of MLH1 was associated with microsatellite instability in most cases. The number of genes methylated in individual lesions increased as cellular atypia increased. In individual patients, cancers adjacent to dysplasia had the same epigenetic alterations as the less advanced lesions but often had additional methylation of other genes. Conclusions: These findings suggest that epigenetic progression parallels the histologic changes observed in the progression of squamous carcinoma of the esophagus.

Original languageEnglish (US)
Pages (from-to)4515-4522
Number of pages8
JournalClinical Cancer Research
Volume12
Issue number15
DOIs
StatePublished - Aug 1 2006
Externally publishedYes

Fingerprint

Epigenomics
Methylation
Esophagus
Squamous Cell Carcinoma
Genetic Promoter Regions
Genes
Neoplasms
Microsatellite Instability
Retinoic Acid Receptors
Methyltransferases
Cadherins
Esophageal Neoplasms
Research Design
Polymerase Chain Reaction
DNA

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Accumulation of promoter methylation suggests epigenetic progression in squamous cell carcinoma of the esophagus. / Guo, Mingzhou; Ren, Jingli; House, Michael; Qi, Yu; Brock, Malcolm V.; Herman, James G.

In: Clinical Cancer Research, Vol. 12, No. 15, 01.08.2006, p. 4515-4522.

Research output: Contribution to journalArticle

Guo, Mingzhou ; Ren, Jingli ; House, Michael ; Qi, Yu ; Brock, Malcolm V. ; Herman, James G. / Accumulation of promoter methylation suggests epigenetic progression in squamous cell carcinoma of the esophagus. In: Clinical Cancer Research. 2006 ; Vol. 12, No. 15. pp. 4515-4522.
@article{471f69db34534b2392403ca3447eac2c,
title = "Accumulation of promoter methylation suggests epigenetic progression in squamous cell carcinoma of the esophagus",
abstract = "Purpose: Squamous esophageal cancer is common in non-Western countries and has a well-defined progression of preinvasive dysplasia leading to invasive squamous cell carcinoma. We examined the changes in promoter region methylation occurring during neoplastic progression. Experimental Design: The frequency of epigenetic changes in the promoter region of 14 genes epigenetically silenced in other cancers was determined and examined the most frequent changes in dysplastic lesions using methylation-specific PCR. Invasive squamous carcinomas, low to high grade dysplasia, and normal esophagus were then examined for methylation changes in the promoter region of each of the eight most commonly methylated genes. Results: Methylation was most frequent for CDKN2A/p16INK4a (52{\%}) but was also common for O6-methylguanine-DNA methyltransferase, E-cadherin (CDH1), and retinoic acid receptor β2. Methylation at individual genes increased in frequency from normal to invasive cancer. Methylation of MLH1 was associated with microsatellite instability in most cases. The number of genes methylated in individual lesions increased as cellular atypia increased. In individual patients, cancers adjacent to dysplasia had the same epigenetic alterations as the less advanced lesions but often had additional methylation of other genes. Conclusions: These findings suggest that epigenetic progression parallels the histologic changes observed in the progression of squamous carcinoma of the esophagus.",
author = "Mingzhou Guo and Jingli Ren and Michael House and Yu Qi and Brock, {Malcolm V.} and Herman, {James G.}",
year = "2006",
month = "8",
day = "1",
doi = "10.1158/1078-0432.CCR-05-2858",
language = "English (US)",
volume = "12",
pages = "4515--4522",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "15",

}

TY - JOUR

T1 - Accumulation of promoter methylation suggests epigenetic progression in squamous cell carcinoma of the esophagus

AU - Guo, Mingzhou

AU - Ren, Jingli

AU - House, Michael

AU - Qi, Yu

AU - Brock, Malcolm V.

AU - Herman, James G.

PY - 2006/8/1

Y1 - 2006/8/1

N2 - Purpose: Squamous esophageal cancer is common in non-Western countries and has a well-defined progression of preinvasive dysplasia leading to invasive squamous cell carcinoma. We examined the changes in promoter region methylation occurring during neoplastic progression. Experimental Design: The frequency of epigenetic changes in the promoter region of 14 genes epigenetically silenced in other cancers was determined and examined the most frequent changes in dysplastic lesions using methylation-specific PCR. Invasive squamous carcinomas, low to high grade dysplasia, and normal esophagus were then examined for methylation changes in the promoter region of each of the eight most commonly methylated genes. Results: Methylation was most frequent for CDKN2A/p16INK4a (52%) but was also common for O6-methylguanine-DNA methyltransferase, E-cadherin (CDH1), and retinoic acid receptor β2. Methylation at individual genes increased in frequency from normal to invasive cancer. Methylation of MLH1 was associated with microsatellite instability in most cases. The number of genes methylated in individual lesions increased as cellular atypia increased. In individual patients, cancers adjacent to dysplasia had the same epigenetic alterations as the less advanced lesions but often had additional methylation of other genes. Conclusions: These findings suggest that epigenetic progression parallels the histologic changes observed in the progression of squamous carcinoma of the esophagus.

AB - Purpose: Squamous esophageal cancer is common in non-Western countries and has a well-defined progression of preinvasive dysplasia leading to invasive squamous cell carcinoma. We examined the changes in promoter region methylation occurring during neoplastic progression. Experimental Design: The frequency of epigenetic changes in the promoter region of 14 genes epigenetically silenced in other cancers was determined and examined the most frequent changes in dysplastic lesions using methylation-specific PCR. Invasive squamous carcinomas, low to high grade dysplasia, and normal esophagus were then examined for methylation changes in the promoter region of each of the eight most commonly methylated genes. Results: Methylation was most frequent for CDKN2A/p16INK4a (52%) but was also common for O6-methylguanine-DNA methyltransferase, E-cadherin (CDH1), and retinoic acid receptor β2. Methylation at individual genes increased in frequency from normal to invasive cancer. Methylation of MLH1 was associated with microsatellite instability in most cases. The number of genes methylated in individual lesions increased as cellular atypia increased. In individual patients, cancers adjacent to dysplasia had the same epigenetic alterations as the less advanced lesions but often had additional methylation of other genes. Conclusions: These findings suggest that epigenetic progression parallels the histologic changes observed in the progression of squamous carcinoma of the esophagus.

UR - http://www.scopus.com/inward/record.url?scp=33748042301&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748042301&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-05-2858

DO - 10.1158/1078-0432.CCR-05-2858

M3 - Article

C2 - 16899597

AN - SCOPUS:33748042301

VL - 12

SP - 4515

EP - 4522

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 15

ER -